Behavior of lymphocytary subpopulations during treatment with dimethyl fumarate in patients with multiple sclerosis

被引：0
|
作者：
Manez Sierra, Minerva [1 ]
Rodriguez Belli, Agustin [1 ]
Delgado Gil, Virginia [2 ]
Padilla Parrado, Fransciso [1 ]
机构：
[1] Univ Hosp Virgen Victoria, Neurol, Malaga, Spain
[2] Hosp Virgen Victoria, Neurol, Malaga, Spain
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷
关键词：
D O I：
10.1016/j.jns.2021.118153
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
118153
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis A Randomized, Controlled Trial
    Chow, Helene Hojsgaard
    Talbot, Jacob
    Lundell, Henrik
    Madsen, Camilla Gobel
    Marstrand, Lisbet
    Lange, Theis
    Mahler, Mie Reith
    Buhelt, Sophie
    Hansen, Rikke Holm
    Blinkenberg, Morten
    Christensen, Jeppe Romme
    Sorensen, Per Soelberg
    von Essen, Marina Rode
    Siebner, Hartwig Roman
    Sellebjerg, Finn
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (05):
  • [22] COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
    Vittorio Mantero
    Lucia Abate
    Paola Basilico
    Roberto Balgera
    Andrea Salmaggi
    Bardia Nourbakhsh
    Christian Cordano
    Journal of Neurology, 2021, 268 : 2023 - 2025
  • [23] Risk of pulmonary embolism in patients with multiple sclerosis on dimethyl fumarate
    Juba, G.
    Bagert, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 941 - 941
  • [24] Liver injury associated with dimethyl fumarate in multiple sclerosis patients
    Munoz, Monica A.
    Kulick, Corrinne G.
    Kortepeter, Cindy M.
    Levin, Robert L.
    Avigan, Mark I.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (14) : 1947 - 1949
  • [25] Cerebrospinal fluid penetration of dimethyl fumarate in patients with multiple sclerosis
    Penner, N.
    Sejbaek, T.
    Woodward, C.
    Edwards, K.
    Mendoza, J.
    Illes, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 486 - 486
  • [26] Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment
    Vollmer, Brandi L.
    Nair, Kavita
    Sillau, Stefan
    Corboy, John R.
    Vollmer, Timothy
    Alvarez, Enrique
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (09): : 1466 - 1476
  • [27] Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis
    Mills, Elizabeth A.
    Ogrodnik, Magdalena A.
    Plave, Andrew
    Mao-Draayer, Yang
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [28] Real world data on teriflunomide and dimethyl fumarate treatment of multiple sclerosis
    Norborg, H.
    Strauss, P.
    Myhr, K-M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 864 - 864
  • [29] Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis
    Liebmann, Marie
    Janoschka, Claudia
    Herrmann, Alexander
    Korn, Lisanne
    Schulte-Mecklenbeck, Andreas
    Schwab, Nicholas
    Kovac, Stjepana
    Gross, Catharina C.
    Konig, Simone
    Meuth, Sven
    Wiendl, Heinz
    Klotz, Luisa
    NEUROLOGY, 2020, 94 (15)
  • [30] Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis
    Charlotte Rastas
    David Sirignano
    Amanda Barner
    Lou Ann Bruno-Murtha
    Journal of Neurology, 2019, 266 : 2867 - 2868
12345